Description
See the financial direction before the treatment commitment.
IMV™ gives organizations managing buy-and-bill infusion therapy a focused financial checkpoint before treatment. In approximately 30–60 seconds, compare your acquisition cost against your expected reimbursement, identify what may need attention, and make more informed financial decisions before committing high-cost therapy.
Your single-practice license includes tools designed to help you recognize financial patterns across therapies, payers and reporting periods, along with support for evaluating alternative products and preparing for payer reimbursement conversations.
Every IMV purchase includes 7 days of complimentary ARIA™ Intelligence. ARIA sits alongside IMV as the interpretation and intelligence layer, helping your practice understand what its financial visibility may be telling you and what deserves attention next.
ARIA becomes increasingly practice-specific through your use of IMV and the financial context available in your workspace.
After the complimentary period, you may choose to continue ARIA Intelligence for $67/month. There is no automatic subscription charge.
Visibility before treatment. Confidence before commitment.
Reviews
There are no reviews yet.